Wells Fargo & Company NOVOCURE LTD Transaction History

Wells Fargo & Company

194,000

Previous 1,303,000 85.11%

Previous $0 NaN%

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	N/A	-1,109,000 Reduced 85.11%	194,000 $0
Q1 2024 May 10, 2024	SELL	N/A	-1,679,000 Reduced 56.3%	1,303,000 $0
Q4 2023 Feb 09, 2024	BUY	N/A	150,000 Added 5.3%	2,982,000 $0
Q3 2023 Nov 13, 2023	SELL	N/A	-250,000 Reduced 8.11%	2,832,000 $0
Q1 2023 May 12, 2023	SELL	N/A	-100,000 Reduced 3.14%	3,082,000 $0
Q2 2022 Aug 12, 2022	SELL	N/A	-7,901,000 Reduced 71.29%	3,182,000 $2.75 Million
Q1 2022 May 16, 2022	BUY	N/A	7,950,000 Added 253.75%	11,083,000 $10.1 Million
Q4 2021 Feb 14, 2022	BUY	N/A	3,133,000 New	3,133,000 $2.92 Million

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.